Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) ...
Tag: Novo Nordisk A/S
Here are the big health sector themes to watch next year
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021.David W. Cerny ...
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
George Frey | Bloomberg | Getty ImagesWeight loss drugs exploded into the public eye this year, and 2024 will bring ...
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Sopa Images | Lightrocket | Getty ImagesPfizer's twice-daily version of its experimental weight loss pill has now joined a long ...
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Pfizer on Tuesday reported a narrower-than-expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to ...
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of new obesity drugs.Dr. Kavita Patel, a physician and NBC News medical ...
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
A box of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk.George Frey | ...
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
The snack aisle is seen during a tour of a new Amazon Go store in the Capitol Hill neighborhood of ...
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know
An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023. Jaap Arriens | ...
Stocks making the biggest moves premarket: Enbridge, Roku, GitLab and more
The Roku app is seen on a television in Hastings-on-Hudson, New York, July 25, 2023.Tiffany Hagler-Geard | Bloomberg | Getty ...
